Do elevated microbial aromatic metabolites reflect altered gut microbial metabolism?

Elevated levels of gut-derived aromatic metabolites serve as sensitive biomarkers, reflecting fundamental shifts in the functional capacity of the intestinal microbiome.

Metabolic origins and clinical relevance

• Dietary precursors and pathways: The aromatic compounds 3-(3-hydroxyphenyl)propionic acid (DHPPA), phenylacetic acid (PAA), 4-hydroxyphenylacetic acid (4-HPAA), and benzoic acid are generated through distinct microbial pathways. DHPPA is produced via the bacterial catabolism of complex plant polyphenols like chlorogenic acid. In contrast, PAA and 4-HPAA are convergent products of both flavonoid (e.g., quercetin) breakdown and the fermentation of the aromatic amino acids phenylalanine and tyrosine. Benzoic acid is a key intermediate in the benzoate-hippurate pathway.
• Indicators of dysbiosis: Because these pathways rely entirely on microbial enzymes, variations in their systemic or urinary excretion signal altered bacterial activity. For example, elevated urinary levels of PAA and 4-HPAA are clinically associated with anaerobic overgrowth and dysbiosis, such as small intestinal bacterial overgrowth (SIBO).

Mechanistic host effects and aging

• Age-related microbial shifts: The aging process is characterized by significant shifts in gut microbiota composition and diversity, which directly alter the metabolic processing of polyphenols and aromatic amino acids.
• Postbiotic signaling: Once synthesized, these aromatic metabolites act as bioactive postbiotics. Rather than inert byproducts, molecules like 4-HPAA and DHPPA circulate systemically to modulate host physiology, exhibiting beneficial properties that reduce systemic inflammation and improve cardiometabolic health parameters.

Bottom line

• Elevated DHPPA, PAA, 4-HPAA, and benzoic acid directly reflect altered gut microbial metabolism of polyphenols and amino acids. Assessing these metabolites provides key clinical insights into dysbiosis, age-related microbiome restructuring, and host inflammatory status.